This study is currently not recruiting participants.

An Open-Label Safety Trial of Svac(Autologous Dendritic Cells Pulsed with Recombinant Human Fusion Protein[Mucin1-Glutathione S-Transferase] Coupled to Oxidized Polymannose) for Epithelial Ovarian Cancer Patients Who Have Progressed During the CAN-003 Stu

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this trial is to assess the safety profile of Cvac for epithelial ovarian cancer patients who were enrolled in the Cvac clinical trial CAN-003 and are no longer eligible for study participation due to disease progression.

Detailed description of study

The purpose of this trial is to assess the safety profile of Cvac for epithelial ovarian cancer patients who were enrolled in the Cvac clinical trial CAN-003 and are no longer eligible for study participation due to disease progression.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ovarian Cancer
  • Age: 100 years or below
  • Gender: All
Updated on 13 Jan 2012. Study ID: 1108006600

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team